Profil

Ben Djemaa Sanaa

GIGA Molecul. Biolog. of Diseases - Gene Expression & Cancer

Département des sciences biomédicales et précliniques

See author's contact details
ORCID
0000-0002-7844-4205
Main Referenced Co-authors
Berger, Manon  (5)
Debuigne, Antoine  (5)
Lechanteur, Anna  (5)
Mottet, Denis  (5)
Piel, Géraldine  (5)
Main Referenced Keywords
Chitosan (2); gene delivery (2); PEG alternative (2); SPION (2); Superparamagnetic iron oxide nanoparticles (SPION) (2);
Main Referenced Unit & Research Centers
CERM - Center for Education and Research on Macromolecules - ULiège [BE] (1)
CESAM - Complex and Entangled Systems from Atoms to Materials - ULiège [BE] (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (6)
Human health sciences: Multidisciplinary, general & others (4)
Chemistry (2)
Materials science & engineering (1)
Oncology (1)

Publications (total 12)

The most downloaded
124 downloads
Ben Djemaa, S., Hervé-Aubert, K., Lajoie, L., Falanga, A., Galdiero, S., Nedellec, S., Soucé, M., Munnier, E., Chourpa, I., David, S., & Allard-Vannier, E. (2019). gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line. Biomacromolecules, 20 (8), 3076-3086. doi:10.1021/acs.biomac.9b00637 https://hdl.handle.net/2268/290874

The most cited

38 citations (Scopus®)

Ben Djemaa, S., David, S., Hervé-Aubert, K., Falanga, A., Galdiero, S., Allard-Vannier, E., Chourpa, I., & Munnier, E. (October 2018). Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis. European Journal of Pharmaceutics and Biopharmaceutics, 131, 99-108. doi:10.1016/j.ejpb.2018.07.024 https://hdl.handle.net/2268/290873

Debuigne, A., Berger, M., Toussaint, F., Ben Djemaa, S., Jérôme, C., Lechanteur, A., Mottet, D., & Piel, G. (24 April 2024). Poly(N-vinyl amide)-lipid conjugates as poly(ethylene glycol) alternatives for the modification of lipid-based nanocarriers [Paper presentation]. Materials Research Society (MRS) Spring Meeting, Seattle, United States.

Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (2023). Polymer Derivative and their use as lipid nanoparticle modifiers”.

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (30 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting), Rotterdam, Netherlands.

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (09 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 2022 Meeting of the Germany and BeNeLux & France Local Chapters of the Controlled Release Society in Aachen, Aachen, Germany.

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Debuigne, A., Mottet, D., Lechanteur, A., & Piel, G. (May 2021). Impact of amphiphilic N-vinyl pyrrolidone-based polymers used as PEG alternative on lipoplexes physico-chemical properties, cytotoxicity and gene delivery [Poster presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Bruniaux, J., Allard-Vannier, E., Aubrey, N., Lakhrif, Z., Ben Djemaa, S., Eljack, S., Marchais, H., Hervé-Aubert, K., Chourpa, I., & David, S. (05 October 2019). Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency. International Journal of Pharmaceutics, 569, 118572. doi:10.1016/j.ijpharm.2019.118572
Peer Reviewed verified by ORBi

Ben Djemaa, S., Munnier, E., Chourpa, I., Allard-Vannier, E., & David, S. (15 August 2019). Versatile electrostatically assembled polymeric siRNA nanovectors: Can they overcome the limits of siRNA tumor delivery? International Journal of Pharmaceutics, 567, 118432. doi:10.1016/j.ijpharm.2019.06.023
Peer Reviewed verified by ORBi

Ben Djemaa, S., Hervé-Aubert, K., Lajoie, L., Falanga, A., Galdiero, S., Nedellec, S., Soucé, M., Munnier, E., Chourpa, I., David, S., & Allard-Vannier, E. (2019). gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line. Biomacromolecules, 20 (8), 3076-3086. doi:10.1021/acs.biomac.9b00637
Peer Reviewed verified by ORBi

Ben Djemaa, S., David, S., Hervé-Aubert, K., Falanga, A., Galdiero, S., Allard-Vannier, E., Chourpa, I., & Munnier, E. (October 2018). Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis. European Journal of Pharmaceutics and Biopharmaceutics, 131, 99-108. doi:10.1016/j.ejpb.2018.07.024
Peer Reviewed verified by ORBi

Ben Djemaa, S., Pacaud, M., Herv -Aubert, K., David, S. P., Allard-Vannier, E., Munnier, E., Ignatova, A., Fahmi, A., Feofanov, A., & Chourpa, I. (August 2018). Fluorescence Microscopy as a Tool for Nanomedicine-Cell Interactions Study: Input of Particle Design and of Analytical Strategy. Microscopy and Microanalysis, 24 (S1), 1316 - 1317. doi:10.1017/S1431927618007067
Peer Reviewed verified by ORBi

Bruniaux, J., Ben Djemaa, S., Hervé-Aubert, K., Marchais, H., Chourpa, I., & David, S. (05 November 2017). Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics. International Journal of Pharmaceutics, 532 (2), 660-668. doi:10.1016/j.ijpharm.2017.05.022
Peer Reviewed verified by ORBi

Abdelrahman, M., Douziech Eyrolles, L., Alkarib, S. Y., Hervé-Aubert, K., Ben Djemaa, S., Marchais, H., Chourpa, I., & David, S. (30 August 2017). siRNA delivery system based on magnetic nanovectors: Characterization and stability evaluation. European Journal of Pharmaceutical Sciences, 106, 287-293. doi:10.1016/j.ejps.2017.05.062
Peer Reviewed verified by ORBi

Contact ORBi